Oncology Today with Dr Neil Love

Latest Episodes:

Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances Jun 17, 2025

Show notes

Prof Meletios-Athanasios (Thanos) C Dimopoulos from the National and Kapodistrian University of Athens and Alexandra Hospital in Athens, Greece, and Dr Robert Z Orlowski from The University of Texas MD Anderson Cancer Center in Houston, Texas, provide their perspectives on relevant new clinical data in multiple myeloma and their application to disease treatment.

CME information and select publications here.

For Oncology Nurses: Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS Congress Jun 16, 2025

Show notes

Drs Virginia F Borges and Seth Wander summarize the treatment landscape for patients with hormone receptor-positive breast cancer, supported with clinical perspectives and management strategies from nurse practitioners Ms Jamie Carroll and Mr Ronald Stein.

NCPD information and select publications here.

For Oncology Nurses: Gastroesophageal Cancer — Proceedings from the 2025 Annual ONS Congress Jun 12, 2025

Show notes

Dr Sunnie Kim and Dr Manish Shah summarize the clinical treatment landscape for patients with gastroesophageal cancers, supported by clinical perspectives and management strategies from oncology nursing experts Ms Brooke Parker and Ms Michal Segal.

NCPD information and select publications here.

Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances Jun 11, 2025

Show notes

Professor Claire Harrison from the Guy’s and St Thomas’ NHS Foundation Trust in London, United Kingdom, and Dr John Mascarenas from The Tisch Cancer Institute in New York, New York, provide their perspectives on relevant new clinical data in myelofibrosis and discuss their application to treatment.

CME information and select publications here.

Non-Small Cell Lung Cancer and Therapeutic Targets Beyond EGFR — Year in Review Series on Relevant New Datasets and Advances Jun 09, 2025

Show notes

Dr Jessica J Lin from Massachusetts General Hospital in Boston and Dr Joel W Neal from Stanford Cancer Institute in California summarize major treatment advances over the past year and review relevant ongoing clinical trials using targeted therapies for patients with non-small cell lung cancer.

CME information and select publications here.

For Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS Congress Jun 06, 2025

Show notes

Dr Ritu Salani and Dr Brian Slomovitz and nurse practitioners Ms Kathryn Lyle and Ms Jaclyn Shaver discuss datasets guiding treatment decision-making for patients with endometrial cancer and strategies to mitigate and manage treatment-emergent adverse events.

NCPD information and select publications here.

Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances Jun 05, 2025

Show notes

Dr Stephen Ansell from Mayo Clinic in Rochester, Minnesota, and Dr Brian Hill from Cleveland Clinic Taussig Cancer Institute in Ohio summarize major treatment advances over the past year and review relevant ongoing clinical trials for patients with non-Hodgkin lymphoma.

CME information and select publications here.

Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances Jun 04, 2025

Show notes

Dr Ian Krop from Yale Cancer Center in New Haven, Connecticut, and Dr Sara Tolaney from Dana-Farber Cancer Institute in Boston, Massachusetts, summarize major treatment advances over the past year and review relevant ongoing clinical trials for patients with breast cancer.

CME information and select publications here.

Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting Jun 03, 2025

Show notes

Dr Leonard G Gomella from the Sidney Kimmel Cancer Center in Philadelphia, Pennsylvania, Dr Evan Y Yu from the Fred Hutchinson Cancer Center in Seattle, Washington, and Dr Daniel George from Duke Cancer Institute in Durham, North Carolina, discuss important clinical datasets and patient cases relevant to AKT inhibition in the care of patients with prostate cancer.

CME information and select publications here.

Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit Jun 02, 2025

Show notes

Clinical investigators discuss available data guiding the management of systemic mastocytosis and myelofibrosis. 

CME information and select publications here.